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Summary Clinical trials in patients with pacemakers for sinus node dysfunction or atri-
oventricular block have highlighted the fact that desynchronization of ventricular contraction
induced by right ventricular apical pacing is associated with long-term morbidity and mor-
tality. These clinical data conﬁrm pathophysiological results indicating that right ventricular
apical pacing causes abnormal ventricular contraction, reduces pump function and leads to
myocardial hypertrophy and ultrastructural abnormalities. In this manuscript, we discuss the
clinical evidence for the adverse and beneﬁcial effects of various right ventricular pacing sites,
left ventricular pacing sites and biventricular pacing. We also propose a decisional algorithm
for pacing modalities, based on atrioventricular conduction, left ventricular function and
expected lifespan.








Résumé Les essais cliniques réalisés chez les patients stimulés pour une dysfonction
sinusale ou un bloc auriculoventriculaire ont mis en évidence une relation de causalité entre
l’asynchronisme de contraction ventriculaire induite par la stimulation ventriculaire droite
apicale et la morbimortalié à long terme de ces patients. Ces données viennent conﬁrmer les
résultats physiopathologiques qui montrent que la stimulation ventriculaire droite engendre
des anomalies de la cinétique ventriculaire, réduit la fonction contractile et induit une
hypertrophie et des anomalies ultrastructurales myocardiques. Dans cet article, les auteurs
détaillent les avantages et les inconvénients des sites de stimulation ventriculaire droite,
gauche ou biventriculaire et proposent un arbre décisionnel pour une stimulation cardiaque
physiologique, basé sur la conduction auriculoventriculaire, la fraction d’éjection ventriculaire
gauche et l’espérance de vie.
© 2008 Elsevier Masson SAS. Tous droits réservés.
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AI/R single-chamber rate-responsive atrial
DD/R dual-chamber rate-responsive
VEF left ventricular ejection fraction
YHA New York Heart Association
VP managed ventricular pacing
VI/R single-chamber rate-responsive ventricular
Cardiac pacing is still the only effective treatment
or severe cardiac impulse formation or propagation dis-
urbances. Despite nearly 50 years having elapsed since
he ﬁrst human implantations [1], the optimal pacing
ode and ventricular pacing site have not been deﬁned
learly.
athophysiological consequences of right
entricular apical pacing
he right ventricular apex is the pacing site that is used most
requently, because it can be reached easily and allows a
hronically stable position and stimulation threshold. How-
ver, even if apical pacing results in haemodynamically
fﬁcient contraction, it remains antiphysiological, because
he wave front propagates slowly through the common
yocardium with no capture of the His-Purkinje system.
he adverse consequences of right ventricular apical pac-
ng were shown more than 80 years ago in mammals [2],
ut only recently in humans [3]. The deleterious effect is
ue to the asynchrony of ventricular activation; myocardial
egions located close to the pacing lead contract ﬁrst and
tretch not-yet-activated remote regions. By virtue of the
ocal Frank—Starling mechanism, this stretching increases
he force of the local contraction of these remote regions
nd, in turn, stretches — paradoxically — regions activated
arlier [4].
Using two models of pacing-induced cardiomyopathies,
pragg et al. studied the effects of asynchronous ventricular
ctivation on the expression of proteins involved in myocyte
ontraction and arrhythmia vulnerability [5]. In cardiomy-
pathies induced by high-rate right ventricular apical
acing, they observed signiﬁcant differences in the expres-
ion of these proteins, whereas such a gradient was not
oted in high-rate atrial-pacing-induced cardiomyopathies
n which ventricular activation was synchronous. The lateral
eft ventricular free wall (late-activated) shows the most
ronounced cellular derangements, such as down-regulation
f protein kinases, proteins involved in calcium homeostasis
nd intercellular connections. The heterogeneous expres-
ion of these proteins creates an intramyocardial gradient,
hich can lead to ventricular dysfunction and may favour
rrhythmia genesis. Other authors have demonstrated that
rolonged right ventricular apical pacing induces dystrophic
bro-fatty myocardial tissue development, mitochondrial
isorganization [6], perfusion abnormalities and localized
ypertrophy of the late-contracting myocardial regions
7].
Haemodynamically, asynchronous myocardial contrac-
ion decreases signiﬁcantly the stroke volume and shifts
ightward the left ventricular end-systolic pressure—volume
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ate-contracting regions leads to a decrease in left ventric-
lar ﬁlling time and Doppler E-wave velocities [8].
linical consequences of right ventricular
pical pacing
wo decades ago, the development of dual-chamber pac-
ng represented a signiﬁcant technological improvement; it
llowed ventricular pacing to be synchronized with the atria
nd was hence adopted quickly as the ‘physiological’ pacing
ode. However, large randomized clinical trials showed that
espite the maintenance of auriculoventricular synchrony,
DD/R pacing did not reduce death compared with VVI/R
acing [9], and provided only modest beneﬁts in progression
f heart failure and atrial ﬁbrillation [10,11], which became
vident only after many years of follow-up [10].
The inability to show a clear superiority of ‘physiological’
ual-chamber pacing over ‘non physiological’ ventricular
acing might be explained by the right ventricular pacing
hat is performed in both modes. A retrospective analysis
f the MOST [12] and MADIT [13] studies showed that the
isks of atrial ﬁbrillation and heart failure hospitalization
re linked directly to the cumulative percentage of ven-
ricular pacing, regardless of pacing mode. Furthermore,
he DAVID trial [14] was terminated prematurely because
f the high incidence of death and worsening of heart fail-
re in the DDD/R (70 beats/min) pacingmode compared with
he VVI/R (40 beats/min) mode. Conversely, single-chamber
trial pacing in patients with sinus node dysfunction pre-
erves left ventricular function and reduces the incidence of
trial ﬁbrillation signiﬁcantly compared with dual-chamber
acing [15].
lternatives to right ventricular apical
acing
ecognition of the adverse effects associated with right ven-
ricular apical pacing fuelled research aimed at ﬁnding a
eans of abolishing or at least reducing these effects. Two
trategies have been investigated: the ﬁrst favours sponta-
eous atrioventricular conduction to minimize unnecessary
entricular pacing; the second involves pacing alternative
entricular sites to attenuate the deleterious effects of right
entricular apical pacing in patients in whom atrioventricu-
ar conduction is absent or unreliable.
inimizing unnecessary ventricular pacing
n cases of sinus node dysfunction, AAI/R pacing prevents
xcessive bradycardia, provides chronotropic support if
eeded and hence corrects symptoms without any risk of
dverse effects due to ventricular pacing. However, the risk
f atrioventricular block in these patients, although low
annual incidence estimated at 1% [16]), leads in most cases
o the implantation of a dual-chamber device without a sig-
iﬁcant increase in the cost-effectiveness of the procedure.
rogramming long atrioventricular delays with hysteresis
an additional increase in the atrioventricular delay) in the
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percentage of ventricular pacing cannot be avoided, espe-
cially in cases where there is a long PR interval.
More recently, new atrial-based ‘dual-chamber mini-
mal ventricular pacing’ modes have been developed to
reduce undesirable ventricular pacing without risk of symp-
tomatic atrioventricular block. Functioning in an AAI/R
pacing mode, these pacemakers (AAISafeR® [Sorin Group])
and MVP®(Medronic) can pace (or detect) atria and moni-
tor the atrioventricular conduction. If a critical number of
P waves are not followed by a QRS complex, the pacemaker
switches automatically to the DDD/R pacing mode. The
MVP mode allows respective reductions of 99.1 and 60.1%
in ventricular pacing in patients with sinus node disease
and atrioventricular block compared with the DDD/R mode,
without sacriﬁcing atrioventricular synchrony [17]. Accord-
ing to the recent pacing guidelines of the European Society
of Cardiology [18], these atrial-based minimal ventricular
pacing modes are now recommended (class IIa, level of evi-
dence C) as an alternative to conventional dual-chamber
pacing in patients who essentially need atrial support.
Alternative ventricular pacing sites
Right ventricular pacing sites
Ventricular pacing may be unavoidable in many patients
because of unreliable or absent atrioventricular conduc-
tion or permanent atrial ﬁbrillation; interest has therefore
focused on alternative ventricular pacing sites that can pro-
vide haemodynamic support without the adverse effects of
apical pacing. Because pacing leads are usually implanted
along the transvenous route, right ventricular pacing sites
have been studied more intensively than other sites.
Direct His bundle pacing is an attractive alternative in
cases of suprahisian atrioventricular block [19,20]. His cap-
ture induces normal propagation of the impulse along the
Purkinje system, thereby preserving the physiological ven-
tricular activation sequence [21]. Studies from Deshmukh
et al. [19] deﬁned selective Hisian pacing criteria: (1) His-
Purkinje-mediated cardiac activation and repolarization, as
evidenced by electrocardiogram concordance of QRS and T-
wave complexes; (2) the pace-ventricular interval (Vp-V)
almost identical to the His-ventricular interval (H-V); (3)
output criteria (the His bundle is captured at low output,
while both the His bundle and ventricular ﬁbres are captured
when the output is increased [widening of QRS complex
at high output]). In 2004, the same authors [20] published
a series of 54 patients with dilated cardiomyopathy, LVEF
23± 11%, permanent atrial ﬁbrillation and QRS duration less
than 120ms, in whom selective Hisian pacing was obtained
in 66% of cases. After a follow-up of 42 months, 29 patients
were still alive and improvements in the ejection fraction
and in clinical and haemodynamic parameters of left ven-
tricular functioning had been achieved.
Recently, Zannon et al. [22] published a study demon-
strating the feasibility of direct Hisian pacing in 24 of 26
patients with a standard pacemaker indication and pre-
served His-bundle conduction. However, the time needed
to reach the His bundle with the permanent catheter var-
ied from 2 to 60min, and approximately 3.8± 2.5 attempts
were required. The acute pacing threshold was 2.3± 1 V (at





These studies have shown that permanent pacing of the
is bundle is a reliable and effective method for preventing
he desynchronization and negative effects of right ventric-
lar apical pacing. However, it is a complex method that
equires longer implant times, cannot be carried out in all
atients and presents high-pacing thresholds. There is also
he theoretical risk of His bundle damage and blockade,
nduced by the trauma and injury caused by the screw-in
ead.
Positioning of the stimulation lead on the upper interven-
ricular septum, close to the His bundle but without pacing it
irectly, allows capture of the septum and, secondarily, the
is-Purkinje system. This approach results, therefore, in a
RS complex that is slightly different from the intrinsic one,
ithout impairing synchronous activation of the heart. The
erm para-Hisian pacing has been used by Deshmukh et al.
19] to deﬁne this form of stimulation, reﬂecting the elec-
rophysiological manoeuvre used currently to differentiate
etrograde conduction over the AV node from conduction
ver an accessory AV pathway [23]. This pacing site differs
rom selective Hisian pacing in that pacing thresholds are
ower, paced QRS complexes are larger and increasing the
utput induces QRS shortening because the His bundle is
aptured [24].
Occhetta et al. [25] compared para-Hisian to right ven-
ricular apical pacing in 16 patients who were implanted
ith a dual-chamber pacemaker connected to a screw-in
ead positioned in close proximity to the His bundle and
o a right ventricular apical lead. After two randomized 6-
onth periods of either para-Hisian or conventional pacing,
he authors showed that para-Hisian pacing was associated
ith a signiﬁcant improvement in NYHA functional class,
xercise tolerance, quality of life score, mitral and tricus-
id regurgitation severity, and interventricular mechanical
elay. With a mean follow-up of 21 months per patient,
he pacing threshold remained stable (implant 0.7± 0.5 V;
ollow-up 0.9± 0.7 V; p = 0.08). The ejection fraction main-
ained medium- to long-term stable values, conﬁrming that
ara-Hisian pacing can prevent deterioration of left ventric-
lar function [25].
Hisian and para-Hisian pacing sites are incontestably the
ost physiological and thus the least deleterious, but are
elatively laborious to use. Septal pacing, however, seems
o be achieved more easily. Victor et al. [26] compared the
hort-term (3-month) effects of septal pacing at the junc-
ion between the upper and middle septal segments with
hose of right ventricular apical pacing in 28 patients with
trial ﬁbrillation who underwent ablation of the atrioven-
ricular node. Septal pacing was associated with a shorter
RS duration (145± 4ms versus 170± 4ms; p < 0.01) and a
ormal QRS axis. Alteration of left ventricular pump func-
ion was observed only in patients whose preimplant LVEF
as less than or equal to 45%. In a study randomizing septal
nd apical pacing, Tse et al. [27] observed alteration of left
entricular function only after 18 months of apical pacing.
hese results seem to indicate that long-term septal pacing
revents left ventricular function deterioration, especially
f the preimplant LVEF is low. However, larger randomized
tudies are needed to obtain further conﬁrmation.
The right ventricular outﬂow tract is the pacing site
hat has been studied most extensively. de Cock et al.













































































































ompared with the right apex. However, the ROVA trial —
randomized crossover study in patients with permanent
trial ﬁbrillation — had a neutral outcome after a 3-month
urvey [29]. These studies were limited by small numbers of
atients and the absence of precise positioning of the pacing
ead within the right ventricular outﬂow tract. Despite the
act that it is the most favourable site, the septal wall was
aced in only 61% of cases of right ventricular outﬂow tract
acing [30]. Mond et al. [31] described a technique that can
acilitate deployment of the lead speciﬁcally into the sep-
al wall of the right ventricular outﬂow tract. The technique
onsists of performing the stylet with a generous distal curve
nd a posterior angulation on the distal 2 cm, and enabled
he septal wall to be reached in all cases. The authors con-
ider it to be a simple and reproducible technique that can
ncrease the comparability of right ventricular outﬂow tract
acing studies.
eft ventricular pacing sites
n patients with normal left ventricular function, left ven-
ricular pacing has been shown to be less harmful than
ight ventricular apical pacing [32]. Furthermore, pacing
t the inferoapical left ventricular septum and the epi-
ardium of the left ventricular apex yields a left ventricular
umping function that closely approximates function dur-
ng normal ventricular conduction [33]. These results may
e explained by the rapid engagement of the specialized
onduction systems in the left ventricular wall near its
break-out’ site [33]. Left ventricular apex pacing can be
chieved by minithoracomy, making this site attractive for
aediatric patients, in whom leads are often positioned
picardially and the previsionnal pacing duration is often
ong.
Blanc et al. [34] assessed the outcome of 22 patients
ith left bundle branch block who were NYHA functional
lass III or IV and were paced transvenously exclusively in
he left ventricle. After 12 months, the authors noted a
igniﬁcant improvement in functional capacities and blood
orepinephrine levels, a reverse remodelling with a signiﬁ-
ant increase in the LVEF and a decrease in left ventricular
iameters [34]. Other immediate positive results of left
entricular pacing have been reported by Nelson et al.
35]; pacing the left ventricle improves the strength of
ts contractions (dP/dt), with a consequent decrease in
yocardial oxygen consumption. These favourable effects
an be explained by the ventricular asynchrony observed
n patients with left bundle branch block. As the left
ateral wall contraction is delayed markedly, its prema-
ure stimulation resynchronizes its contraction with that
f the septal wall [36,37], resulting in a decrease in
itral regurgitation and an improvement in contraction
ffectiveness [38]. It should be noted, however, that
hese results can only be applied to left bundle branch
lock patients and that there are actually no data sup-
orting isolated left ventricular pacing in patients with
trioventricular block and normal ventricular activation
equence.iventricular pacing
ecause right ventricular apical pacing results in an activa-
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eemed reasonable to predict that the results of upgrad-
ng dual-chamber pacemakers to a biventricular device
n patients with left ventricular dysfunction would be as
avourable as those of biventricular pacing in patients with
eft bundle branch block [39]. However, when the haemo-
ynamic conditions of patients with atrial ﬁbrillation who
nderwent atrioventricular node ablation and were paced
nly in the right ventricular apex were compared with those
f similar patients whowere paced biventricularly, the bene-
t of biventricular pacing did not appear to be so pronounced
40]. This may be due to the fact that the beneﬁt obtained
y the rate control itself minimizes considerably the adverse
ffects of right apical pacing.
Marai et al. [41] compared the modiﬁcations in functional
lass and echocardiographic indices induced by upgrading
f patients paced previously for conventional indications
ith those in patients paced de novo with a resynchroniza-
ion device. Despite the small and retrospective enrolment
n this study, the results showed clearly that the improve-
ents noted in each population were similar and allowed the
uthors to conclude that patients paced at the right ventric-
lar apex, and with validated criteria for resynchronization,
eneﬁt from a biventricular device [41].
Furthermore, in a cross-over randomized study of
atients paced previously at the right ventricle, who were
YHA functional class III or IV despite optimal drug treat-
ent and had ventricular dyssynchrony (interventricular
elay > 40ms or left ventricular pre-ejection delay >140ms),
eclercq et al. [42] showed that biventricular stimulation
mproved NYHA functional class, 6-min walked distance and
uality of life score by 18, 29, and 19%, respectively, com-
ared with single right ventricular pacing.
Based on this growing evidence, the authors of cardiac
acing and resynchronization therapy guidelines recom-
end the use of a biventricular device in heart failure
atients with NYHA functional class III—IV symptoms, LVEF
ess than or equal to 35%, left ventricular dilation and
conventional indication for permanent pacing. In these
atients, preimplantation QRS duration greater than or
qual to 120ms is no longer a selection criterion [18].
odalities of physiological pacing
iven the various data presented previously, it appears that
he choice of pacing mode and site must draw on several
ariables that can be integrated into a decisional algorithm
Fig. 1).
The choice of pacing mode must be preceded by an
ssessment of atrioventricular and intraventricular conduc-
ion. If they are normal (sinus node dysfunction) or in cases
f intermittent atrioventricular block, an atrial-based dual-
hamber with minimal ventricular pacing is recommended.
his strategy avoids deleterious unnecessary ventricular
acing and prevents bradycardia due to unpredictable atri-
ventricular block. However, if the atrioventricular block
s permanent, ventricular pacing support becomes unavoid-
ble. Many studies have shown that heart failure induced by
entricular dyssynchrony develops after many years of apical
acing [43], which is why right ventricular apical pacing can
e advised in the elderly population with atrioventricular
lock and short life expectancy.

















aFigure 1. Proposed decisional algorithm for physiological cardiac
of implant.
As far as resynchronization is concerned, indications are
not clearly deﬁned. In a subgroup analysis of the DAVID
trial [44], patients with abnormal intraventricular conduc-
tion (QRS duration ≥110ms) had worse outcomes after
right ventricular apical pacing than those with narrow QRS
complexes. In the MOST study, only 10% of patients had
heart failure during follow-up; they were more likely to
have a lower ejection fraction, myocardial infarction and
a worse NYHA functional class compared with patients
who did not experience heart failure [45]. The APAF study
[46] aimed to assess whether the extent of left ventricu-
lar asynchrony during right ventricular apical pacing could
be predicted by clinical, electrocardiographic or echo-
graphic ﬁndings obtained during sinus rhythm. The main
conclusion was that an abnormal baseline electromechan-
ical left ventricular delay and a QRS duration greater
than 85ms were independent predictors of an abnormal
electromechanical left ventricular delay during right ven-
tricularpacing.
Thus, biventricular pacing may be beneﬁcial for patients
with pre-existing left ventricular dysfunction (LVEF < 35%)





yng in patients without signs of congestive heart failure at the time
ither on echo- or electrocardiography (abnormal intracar-
iac conduction), who are more likely to develop progressive
eart failure after right ventricular apical pacing. Dual-
hamber conventional pacing in patients without any clinical
r echocardiographic sign of ventricular dyssynchrony seems
cceptable as there is no evidence as yet favouring biven-
ricular pacing. In all patients paced in the right ventricle,
lose echocardiograpic monitoring must be carried out to
etect any worsening of left ventricular function, which
ould then justify upgrading.
Ongoing studies [47,48] address this issue speciﬁcally.
IOPACE [48] compares the long-term effects (5-year follow-
p) of conventional dual-chamber and biventricular pacing
n patients without any indication for resynchronization.
LOCK HF [47] is a randomized trial designed to determine,
n terms of time to ﬁrst cardiac event, whether patients with
trioventricular block, left ventricular dysfunction (LVEF
50%) and mild-to-moderate heart failure (NYHA functional
lass I—III), and who require pacing, beneﬁt from biventricu-
ar pacing compared with right ventricular pacing alone. The
esults of these studies are expected to deﬁne clearly the






































he concept of an ideal pacing modality is nothing but a
ream. The realistic goal is to minimize impairment of left
entricular function. If ventricular pacing is needed, careful
valuation of spontaneous atrioventricular conduction and
VEF is mandatory. If atrioventricular conduction is main-
ained most of the time, every effort should be made to
void unnecessary ventricular pacing. When the ventricle
as to be paced frequently and ventricular function is not
everely impaired, right ventricular pacing can be adopted,
s alternative pacing sites have not shown any superiority
hus far. In patients with severe left ventricular dysfunc-
ion and in whom permanent ventricular pacing is needed,
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